Peter Soparkar serves as Executive at Adverum Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Peter Soparkar has executed 12 insider transactions totaling $408.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved receiving (via award) 150,000 shares valued at $0.
Peter Soparkar currently holds 157,333 shares of Adverum Biotechnologies, Inc. (ADVM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Soparkar has been a net buyer of ADVM stock. They have purchased $383.7K and sold $24.7K worth of shares.
Peter Soparkar's most recent insider trade was on Dec 9, 2025, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 9, 2025 | ADVM | $0 | Tender | 13,125 | $N/A | Discretionary |
| Dec 9, 2025 | ADVM | $0 | Tender | 80,189 | $N/A | Discretionary |
| Dec 5, 2025 | ADVM | $211.0K | Purchase | 50,000 | $4.22 | Discretionary |
| Mar 15, 2023 | ADVM | $10.4K | Sale | 13,360 | $0.78 | Discretionary |
| Sep 19, 2022 | ADVM | $14.2K | Sale | 13,305 | $1.07 | Discretionary |
| Apr 19, 2022 | ADVM | $24.8K | Purchase | 21,750 | $1.14 | Discretionary |
| Apr 19, 2022 | ADVM | $200 | Purchase | 175 | $1.14 | Discretionary |
| Dec 8, 2021 | ADVM | $47.8K | Purchase | 25,000 | $1.91 | Discretionary |
| Aug 6, 2021 | ADVM | $0 | Award | 220,000 | $N/A | Discretionary |
| Aug 17, 2020 | ADVM | $100.0K | Purchase | 7,692 | $13.00 | Discretionary |